MSD Japan Set To Launch Orexin Antagonist Sleeping Pill
This article was originally published in PharmAsia News
Executive Summary
MSD will enter the insomnia drug market in Japan with the launch of Belsomra (suvorexant) this fall, which will be the first orexin antagonist to be launched in the country.